Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial is a research paper published in EClinicalMedicine (2021). On theSindex it has a DataRank of 2.8. It has been cited 65 times, with 55 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.628
From this paper's citation signal
Citation Network Contribution
2.2
From 47 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 55 citers.
NIAID NIH HHS
Grant: T32 AI007044
National Institutes of Health
Grant: 3UL1TR002319-02S1
Transform Dissemination and Implementation Science in CTSA Programs
National Institutes of Health
Grant: 5TL1TR002318-07
NRSA Training Core
National Institutes of Health
Grant: 1KL2TR002317-01
Institute of Translational Health Sciences
Bill and Melinda Gates Foundation
FWCI
6.82
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals